Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
Not Applicable
Recruiting
- Conditions
- Tricuspid Regurgitation FunctionalTricuspid Regurgitation
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Innoventric LTD
- Target Recruit Count
- 15
- Registration Number
- NCT06212193
- Locations
- 🇺🇸
Cardiovascular Institute of Los Robles Health System, Thousand Oaks, California, United States
🇺🇸Ascension St. John, Detroit, Michigan, United States
🇺🇸Mayo Clinic Hospital (Rochester), Rochester, Minnesota, United States
Innoventric Trillium™ Stent Graft First-in-Human (FIH) Study
Not Applicable
Active, not recruiting
- Conditions
- Tricuspid Regurgitation
- First Posted Date
- 2020-02-28
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Innoventric LTD
- Target Recruit Count
- 20
- Registration Number
- NCT04289870
- Locations
- 🇧🇪
OLVZ Aalst, Aalst, Belgium
🇧🇪ZNA, Antwerp, Belgium
🇩🇪Heart & Diabetes Center NRW, Bad Oeynhausen, Germany
News
No news found